Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel diazotization process for D-amino acids reduces enzyme use and cost. Reliable supplier for pharma intermediates with scalable production.
Advanced optical resolution process for 2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidine-1-propanone. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Advanced resolution and racemization process for L-synephrine intermediates. Reduces waste and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN113801027A reveals a high-yield synthesis route for dapoxetine hydrochloride offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1894224A reveals a superior ethanol-based resolution process for Nefopam, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Novel benzophenone route for Solifenacin intermediate. Cost-effective, eco-friendly, high purity manufacturing process detailed in patent CN111925266A.
Patent CN112979552A reveals a novel Friedel-Crafts route for Dexmedetomidine HCl, offering 100% purity and superior supply chain stability for pharma manufacturers.
Patent CN104263803B enables high-purity S-2-tetrahydronaphthalene amines production with superior yield and optical purity for reliable pharmaceutical intermediates supply chains.
Patent CN105063164A reveals DKR method for S-6-Methoxy-1-Aminoindane. High purity and yield offer supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN105154513A analysis reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN1323300A details an improved convergent synthesis for novel antidiabetic compounds. Discover cost-effective manufacturing strategies and high-purity intermediate supply solutions.
Patent CN105154514A enables high-purity (S)-5-methyl-1-aminoindane via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN103755582A details a novel direct resolution of DL-serine using cyclic phosphates. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN111302997A reveals a streamlined one-pot method for Raatinib intermediates, offering significant cost and waste reduction for API manufacturing.
Patent CN104263803A details high-purity S-2-tetrahydronaphthalene amine synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104263799A enables high-purity S-2-tetrahydronaphthylamine via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN101985447A details chiral resolution for tetrabenazine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Advanced chemical resolution process for L-Valine and D-Valine using DBTA. Delivers >98% optical purity and scalable manufacturing for pharmaceutical intermediates.